Retatrutide supplied by Power Peptides undergoes analytical verification using high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity
Always check the label and follow the guidance provided by the pharmacy and your healthcare team
Can I slow my tirzepatide dose to reduce menstrual disruption
Meet our doctors Last reviewed: 19 Jun 2026 Sources Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Transdermal drug delivery: overcoming the skin's barrier function, Europe PMC [accessed 14 January 2026] (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteins, Advanced Drug Delivery Reviews, [accessed 14 January 2026] Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, [accessed 14 January 2026]
It should be noted that injectable versions of GHK-Cu are for research purposes only and are not intended for human use